Innovative solutions to
keep your project on course

Modeling and Simulation

With modeling and simulation, your existing data can answer important questions and result in significant savings in future studies. Model-based drug development consists of the use of mathematical and statistical methods to:

  • Understand how various dosing choices (e.g., dose, dose frequency, dosing duration) affect drug concentrations
  • Clarify the relationship between drug concentration and desired or undesired pharmacodynamic responses
  • Characterize the PK/PD variability of drugs and assist in understanding the clinically relevant factors contributing to variability

Nuventra has an expert team of pharmacometricians who build models to guide your future drug development decisions. Our team creates tailored model-based drug development plans, including rational selection of the most salient model for a given investigational compound and disease area.

Our Modeling and Simulation Services:

Explore Our Blog

population modeling

What is the Difference Between PBPK and PopPK Modeling?

“I suppose it is tempting, if the only tool you have is a hammer, to treat everything as if it…

Read More
Drug development

The Importance of Clinical Trial Monitoring and Data Management for Population PK Modeling

What are some of the most common and costly mistakes sponsors make when it comes to collection of pharmacokinetic (PK)…

Read More
Renal Impairment

Is a Renal Impairment Study Needed for NDA or BLA Approval?

Renal Impairment Studies for FDA Approval – Common Questions and Answers Is a renal impairment study needed for your drug…

Read More